Eli Lilly Targets Illegal Sales of Experimental Weight-Loss Drug

Eli Lilly announced that it has filed six lawsuits against wellness vendors. The company accused these vendors of selling illegal versions of its experimental weight-loss medication, retatrutide. This legal action aims to reduce the numerous illicit sales occurring online.

A vial of the drug was observed on a table in Brooklyn, New York, highlighting the ongoing issue. Eli Lilly’s decision reflects efforts to ensure the legitimacy and safety of drug sales, particularly for experimental medications with significant effects.